-+ 0.00%
-+ 0.00%
-+ 0.00%
LSL Pharma Expects Steri-Med Production to Resume by End-November After Remediation
Share
Listen to the news
LSL Pharma Expects Steri-Med Production to Resume by End-November After Remediation
  • LSL Pharma expects Steri-Med production to resume by the end of November 2026 following implementation of key Health Canada-approved remediation measures.
  • Health Canada is expected to visit shortly to assess implementation of the remediation plan.
  • Inventory built up earlier maintained uninterrupted customer supply since the fiscal year's start, including throughout the third quarter.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LSL Pharma Group Inc. published the original content used to generate this news brief via CNW (Ref. ID: 202611170700CANADANWCANADAPR_C0596) on November 17, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending